Market Analysis and Insights: Global Artificial Intelligence in Medicine Market
Artificial intelligence (AI), sometimes called machine intelligence, is intelligence demonstrated by machines, in contrast to the natural intelligence displayed by humans and other animals.
The global Artificial Intelligence in Medicine market size is projected to reach US$ 5972 million by 2030, from US$ 1022.3 million in 2022, at a CAGR of 28.1% during 2023-2030.
Artificial intelligence has revolutionized patient care and enabled the emergence of better healthcare facilities. Managing medical records and other data pertaining to the patients is being delegated to AI systems, which leads to efficient use of resources and reduction of monotony in the jobs.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artificial Intelligence in Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artificial Intelligence in Medicine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Intelligence in Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Intelligence in Medicine market.
Global Artificial Intelligence in Medicine Scope and Market Size
Artificial Intelligence in Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence in Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.
Segment by Type
On-premise
Cloud-based
Segment by Application
Patient Care
Research and Drug Invention
Disease Diagnosis and Identification
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
IBM
Atomwise
Zebra Medical Vision
Cyrcadia Health
AiCure
Modernizing Medicine
Berg Health
Esko Bionics
Medasense Biometrics
Hindsait
